The overseas staff serving the South East NHS
Rishan Belete arrived in the UK from her native Sudan in the back of a lorry at the age of 17, as an unaccompanied minor. That was in 2016. Last year, she qualified as a nurse.Now working in East Kent, she is one of more than 50,000 NHS staff in the wider South East who self-reported as not being British in 2023, many of whom may have come to the UK as migrants. Ms Belete said "learning the language and learning the culture was the hardest thing" about integrating in the UK.
Across Kent Sussex and Surrey approximately 25% of NHS staff are from overseas, but the region still struggles with a vacancy rate of more than 8%. NHS trusts all recruit from overseas to try and fill the gaps they have in their workforce with many describing overseas staff as "vital" to be able to maintain services. Having left Sudan almost a decade ago, Ms Belete travelled to the UK via Libya and then across the Mediterranean sea. She said some people could not accept that she had arrived in the UK illegally.Ms Belete said it was "kind of alarming to people to think that I'm a criminal person". Supported by the Kent Refugee Action Network, Ms Belete was fostered in Kent as an unaccompanied minor and said she watched Emmerdale and Eastenders on TV to help her learn English.It was always her dream to work in the health service."Healthcare, that was really something I was really passionate about," she said.
After qualifying as a nurse in 2009 Joanne Cabiguen left the Philippines to work for the NHS in 2022. Ms Cabiguen now works as a theatre practitioner in Maidstone and Tunbridge Wells.She said at home she was "earning say £75 to £90 per month, which is not very much" and that to come to the UK and work for the NHS was her "dream"."A friend invited me to try the UK and I was like, why not? It's my dream and it's never too late for dreams right?"
Dr Chirollos Romani qualified as a doctor in Italy. He is now a cardiologist and Chief Registrar at Maidstone and Tunbridge Wells NHS Trust. Dr Romani has been working in the NHS for seven years - but remembers how challenging his first few weeks were working in the health service. "The way people communicate in a different country is completely different and you have to get used to it," he said. A patient asked him if she could spend a penny and he replied: "On what?" Dr Romani said when there is a patient in front of you, you are "trying to understand what is going on". "It's like: 'Oh my God, I don't have a grip on this'," he said.
According to Helen Palmer, chief people officer for Maidstone and Tunbridge Wells NHS Trust, overseas staff are "a pipeline of highly experienced, highly skilled staff". "It's absolutely key to us to be able to have that talent pipeline to make sure we are filling our vacancy gaps and really providing the best patient care that we possibly can," she added.
A Department of Health and Social Care spokesperson said: "The NHS has always drawn on talent from around the world. "The service is stronger for it and millions of patients are grateful for the skilled and compassionate care they have received from staff from overseas."They said the government was also committed to developing homegrown talent and giving opportunities to more people across the country to join the NHS, by training thousands more doctors and nurses.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
2 hours ago
- Telegraph
NHS faces paying more for US drugs to avoid future Trump tariffs
Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug pricing to take into account the 'concerns of the president', according to documents released after a trade agreement was signed earlier this year. White House sources said it expected the NHS to pay higher prices for American drugs in an attempt to boost the interests of corporate America. A Westminster source said: 'There's an understanding that we would look at the drug pricing issue in the concerns of the president.' The disclosure is likely to increase concerns about American interference in the British health service, which has long been regarded as a flashpoint in trade talks. It comes after Rachel Reeves announced a record £29 billion investment in the NHS in last week's spending review. The Chancellor's plans will drive spending on the health service up towards 50 per cent of all taxpayer expenditure by the mid-2030s, according to economists at the Resolution Foundation. The Telegraph has also learnt that under the terms of the trade deal with America, the UK has agreed to take fewer Chinese drugs, in a clause similar to the 'veto' given to Mr Trump over Chinese investment in Britain. The White House has asked the UK for assurances that steel and pharmaceutical products exported to the US do not originate in China, amid fears the deal could be used to 'circumvent' Mr Trump's punishing tariffs on Beijing. Mr Trump is enraged by how much more America pays for drugs compared with other countries and considers it to be the same issue as he has raised on defence spending. Just as the US president has heaped pressure on European nations to increase the GDP share they allocate to defence, he thinks they should spend more on drug development. An industry source said: 'The way we've been thinking about it and many in the administration have been thinking about it, it's more like the model in Nato, where countries contribute some share of their GDP.' Britain and the US 'intend to promptly negotiate significantly preferential treatment outcomes on pharmaceuticals and pharmaceutical ingredients', the trade deal reads. Pharmaceutical companies are also pushing for reductions in the revenue sales rebates they pay to the NHS under the voluntary scheme for branded medicines pricing, access and growth (VPAG) – a mechanism that the UK uses to make sure the NHS does not overpay. Non-US countries are 'free-riding' Last week, Albert Bourla, Pfizer's chief executive, said non-US countries were 'free-riding' and called for a US government-led push to make other nations increase their proportionate spend on innovative medicines. He said White House officials were discussing drug prices in trade negotiations with other countries. 'We represent in UK 0.3pc of their GDP per capita. That's how much they spend on medicine. So yes, they can increase prices,' Mr Bourla said. Industry sources said there was no indication yet on what the White House would consider to be a fair level of spending. Whatever the benchmark, Britain will face one of the biggest step-ups. UK expenditure on new innovative medicines is just 0.28pc of its GDP, roughly a third of America's proportionate spending of 0.78pc of its GDP. Even among other G7 nations, the UK is an anomaly. Germany spends 0.4pc of its GDP while Italy spends 0.5pc. Most large pharmaceutical companies generate between half and three quarters of their profits in the US, despite the fact that America typically makes up less than a fifth of their sales. This is because drug prices outside of the US can cost as little as 30pc of what Americans pay. Yet, pharmaceutical companies rely on higher US prices to fund drug research and development, which the rest of the world benefits from. A month ago, Mr Trump signed an executive order titled 'Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients', which hit out at 'global freeloading' on drug pricing. It stated that 'Americans should not be forced to subsidise low-cost prescription drugs and biologics in other developed countries, and face overcharges for the same products in the United States' and ordered his commerce secretary to 'consider all necessary action regarding the export of pharmaceutical drugs or precursor material that may be fuelling the global price discrimination'. Trung Huynh, the head of pharma analysis at UBS, said: 'The crux of this issue is Trump thinks that the US is subsidising the rest of the world with drug prices. 'The president has said he wants to equalise pricing between the US and ex-US. And the way he wants to do it is not necessarily to bring down US prices all the way to where ex-US prices are, but he wants to use trade and tariffs as a pressure point to get countries to increase their prices. 'If he can offset some of the price by increasing prices higher ex-US, then the prices in America don't have to go down so much.' Mr Huynh added: 'It's going to be very hard for him to do. Because [in the UK deal] it hinges on the NHS, which we know has got zero money.' Under VPAG, pharmaceutical companies hand back at least 23pc of their revenue from sales of branded medicines back to the NHS, worth £3bn in the past financial year. The industry is pushing for this clawback to be cut to 10pc, which would mean the NHS would have to spend around 1.54bn more on the same medicines on an annual basis. The Government has already committed to reviewing the scheme, a decision which is understood to pre-date US trade negotiations. A government spokesman said: 'This Government is clear that we will only ever sign trade agreements that align with the UK's national interests and to suggest otherwise would be misleading. 'The UK has well-established and effective mechanisms for managing the costs of medicines and has clear processes in place to mitigate risks to supply.'
Daily Mail
3 hours ago
- Daily Mail
Lucy Letby supporter claims neo-natal unit where baby serial killer worked was 'not fit for purpose'
The Countess of Chester Hospital's neo-natal unit was 'not fit for purpose' before Lucy Letby started murdering babies, a former nurse who worked there has claimed. Michele Worden said redundancies led to a loss of senior staff and plumbing issues created a 'perfect storm' for care failings. The former advanced nurse practitioner left the Countess after being made redundant in 2007, four years before Letby started working and eight years before her killing spree began. She told the Nursing Times that when the unit was downgraded in around 2006 and stopped caring for very premature babies under 27 weeks, senior nurses were replaced with junior staff who were asked to care for infants 'above their capabilities [and] training.' She said: 'It wasn't just the neonatal unit that wasn't fit for purpose, the whole maternity and paediatric and gynaecology… was not fit for purpose. 'The problems with the sewage and blocked sinks were not just [on] the neonatal unit, it was on the labour ward, it was all over.' Ms Worden said she believed the situation at the Countess of Chester was 'no different' to other NHS hospitals where maternity scandals have been uncovered in recent years. 'Hopefully Lucy will be exonerated,' she said. 'Chester is no different than Shrewsbury, Nottingham, Morecambe Bay. Women and children's healthcare has never been a high priority.' Letby, 38, is serving 15 whole life terms after being convicted of the murder of seven babies and attempted murder of seven more, including one baby girl she tried to kill twice. Plumber Lorenzo Mansutti, estates manager at the Countess, was the only witness called by Letby in her defence at her Manchester Crown Court trial. He admitted drainage problems were a 'weekly' issue at the hospital's 50-year-old Women's and Children's Building and told the jury that he remembered an incident when raw sewage backed up into sinks in the intensive care nursery. But he said it was a 'one off' and insisted that at no point were staff unable to wash their hands because the hospital had 'backup' portable handwashing units on site. The problem was not logged as a formal incident, so no exact date for the incident could be found. Letby's trial heard that none of the seven babies who died collapsed due to a bacterial infection associated with poor sewage. Cheshire police are continuing to investigate the former nurse and last year confirmed they had questioned her in prison in connection with more baby deaths. But, following a presentation from 14 international experts in February, who claim none of the babies were murdered but died due to poor care, there has been a continued chorus of people questioning the safety of her convictions. Letby has twice applied and been refused leave to appeal, but her new legal team have submitted a file of evidence to the Criminal Cases Review Commission, the body that investigates potential miscarriages of justice, in a last ditch attempt to get her convictions overturned. They claim the testimony of lead prosecution expert Dewi Evans was biased and that he changed his mind over the method of murder of one of the children murdered by Letby, a boy known as Baby C. Dr Evans has denied this and the Court of Appeal has already dismissed claims he was not suitably qualified or lacked independence. Yesterday it emerged that Dr Evans, who has been subjected to intense trolling online from Letby supporters, had been involved in an online row with one of them - an anonymous statistician who Dr Evans accused of being motivated by a sexual attraction to Letby. According to the statistician, Dr Evans wrote: 'You seem very intense, and it's not unusual for men to have the hots for pretty young blonde females. A nursing uniform is a turn-on for some by all accounts. 'I would suggest you need to get out more, find yourself an available pretty young blonde female, with/without nursing credentials. But one who doesn't go to work intent on murdering her patients.' The statistician said it was 'absurd' to say he believed Letby was innocent because she was 'blonde and pretty' and insisted he had come to that view after reviewing the transcripts of the trial.
BBC News
5 hours ago
- BBC News
Completion of £16m Trowbridge medical centre 'firmly in sight'
The completion of a £16m integrated care centre is "firmly in sight" following the installation of a new roof. The Trowbridge Integrated Care Centre in Wiltshire has been described as a "state-of-the-art health and care facility" and is due to open to patients early next site will become the location for the minor injury unit and X-ray department that are currently based within the nearby Trowbridge Community executive lead for cancer, planned care and community, Caroline Holmes, said: "The building work is well under way, the finish line is firmly in sight, and local people can now see their new integrated care centre really begin to take shape. Using the latest green technology, such as solar panels and heat pumps, the centre is designed to be fully self-sufficient and net zero carbon. Representatives from Bath and North East Somerset, Swindon and Wiltshire Integrated Care Board (ICB) marked the "milestone" occasion on the recently installed were joined by the Mayor of Trowbridge, along with a number of NHS colleagues who will soon call the new centre Holmes thanked those who had helped bring the new centre to added: "When the very first spades went in the ground, it was difficult to picture how a brand new health and care facility could emerge from what was essentially a very muddy field. Yet, here we are."The new centre is set to be a "flagship location" for local health and care, with teams from many different organisations, including HCRG Care Group, Avon and Wiltshire Mental Health Partnership and the Royal United Hospital, working together under one roof.
